eBook

The New Rules of DTC: Pharma & Med Device Marketer's Guide to Growth Without Risk

Direct-to-consumer (DTC) marketing is booming across pharma and med devices, but the same funnels fueling growth are leaking sensitive data, and regulators are watching. HIPAA exemptions no longer guarantee safety as FTC fines, lawsuits, and new state privacy laws rewrite the rules.

This guide reveals where privacy risks hide in your DTC marketing funnel and how to rebuild compliant, high-performance tracking that protects both patient data and ROI.

Expect to learn:

Why even “non-HIPAA covered” pharma and med device marketers are facing FTC and state-level penalties
How everyday pixels and tags on branded sites, co-pay flows, and telehealth pages create legal risk
What new laws mean for consent, compliant advertising, and your DTC strategy

Get The Guide

Trusted by Healthcare

Get a Compliance Check Up

Generate a comprehensive scan of all the pages on your domain(s) to audit what trackers are running where, so you can quickly make the decisions that keep you compliant with privacy laws.

01 (2)

"Freshpaint allows us to do more with less. We really understand where our marketing dollars are going, and we can move those dollars around to drive the best results."

Arden Kaley, VP Growth Marketing

Unlock High Performance
Marketing & Protect Patient Privacy

Freshpaint enables pharmaceutical and medical device companies to unlock performance marketing while staying compliant with a growing list of privacy laws.

By replacing non-compliant tracking tools, Freshpaint empowers marketing teams to accurately measure campaign performance, target the right patients, and improve ROI, all with regulatory compliance baked in.

Freshpaint HIPAA